CARBOGEN AMCIS AG combines world-class chemistry skills to provide seamless drug substance development and commercialization services for leading pharmaceutical and biotechnology companies. Through our customised offering we provide an array of integrated services operated in a fully cGMP compliant infrastructure, including a dedicated High Potency Facility.  These read moreservices supports faster, safer drug development with improved cost efficiency, helping our clients make decisions more quickly and progress more candidates through the pipeline in a shorter period of time. [website]

Patriapharma is the international commercial partner of CF Pharma, Hungary, and draws on the pharmaceutical API development and manufacturing capabilities and extensive experience of its partner, whose R&D team maintains a highly specialized development pipeline.

ChemCon is a contract development and manufacturing partner for APIs and fine chemicals specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. Customers worldwide use our services to source APIs for clinical trials and/or commercial applications (i.e. orphan diseases), excipients, reference standards, and read moreall kinds of other high-quality specialty chemicals. Our FDA-inspected facilities are optimized for the production of small to medium quantities. With multidisciplinary expertise we can meet your individual demands for small-molecule organic APIs, inorganic compounds including trace elements, polymers, and highly potent or controlled substances – all in full cGMP quality up to injection grade. Comprehensive in-house analytics, stability studies, documentation, and regulatory support complete our services. ChemCon can look back on an outstanding inspection history both by the FDA and European health authorities.

Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug read moreproducts. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.

Chiral Quest is a US-based company founded in 2000 and Jiangxi Long Life was founded in 2009 near Nanchang, China. In May 2012 Chiral Quest and Long Life merged to form a single company. Chiral Quest Suzhou is focused on R&D and pilot plant operations and Chiral Quest Long Life read moreis focused on commercial scale manufacture. The combined company has more than 100,000 L of manufacturing capacity, with expertise in high pressure asymmetric hydrogenation and cryogenic reactions. The company has successfully developed and scaled up many processes for the commercial manufacture of both chiral and achiral intermediates. The combination of Chiral Quest’s chiral technology portfolio and Long Life’s low-cost manufacturing provides a unique service offering in China. [website]

Clearsynth Labs Limited is a technology oriented and research driven enterprise with the World's Largest Inventory of High-end research products. Specializes in Stable Isotope Labeled compounds, the synthesis of reference standards, Metabolites, Impurities, Glucuronides, Chiral Compounds and also undertake custom synthesis of complex Molecules or "Difficult to Synthesize" read morecompounds/Intermediates. [website]

CordenPharma is your One Partner CDMO for the global supply of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of fully-inspected cGMP facilities across Europe and the US organized under six technology platforms – Peptides - Lipids & Carbohydrates - Injectables - Highly Potent & Oncology - Small Molecules read more- Oligonucleotides - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-quality products. [website]

CorePharma is a Quality Driven + People Powered™ US based small molecule CDMO. With a robust history of adherence to compliance standards, we prioritize delivering product solutions starting from the developmental phase and extending all the way to a successful commercialization phase. Our commitment to exceptional customer service read moresets an industry benchmark. At the heart of our operations are state of the art facilities dedicated to development, analytical, clinical and commercial manufacturing, and packaging - all of which are run by our experienced team. We are ready to propel your product pipeline from ideation to the patient.

Our chemical development team, comprised of more than 150 scientists in four countries, exceeds expectations on even the most challenging projects. Working in state-of-the-art laboratories equipped with the latest process and analytical instrumentation, we efficiently conduct route scouting, rapid process development, optimization of reaction conditions for scale-up of materials read morefor preclinical trials or large-scale manufacturing non-GMP and GMP. With support from our expert team of analysts, chemical engineers and QA professionals, we rapidly and efficiently develop scalable manufacturing processes to meet any need, including development of high-potency APIs and DEA-licensed controlled substances.